APO Research
Talk to an analyst

APO RESEARCH · REPORT

Toxicity Estimation Software Tool (TEST)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Toxicity Estimation Software Tool (TEST) Market Analysis and Forecast 2026-2032

12 August 2026175 pages

Choose your research edition.

Industry ResearchToxicity Estimation Software Tool (TEST) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Toxicity Estimation Software Tool (TEST) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Toxicity Estimation Software Tool (TEST) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Toxicity Estimation Software Tool (TEST) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Toxicity Estimation Software Tool (TEST) Market Analysis and Forecast 2026-2032175 pages · $4,950 USD

Market perspective

The global Toxicity Estimation Software Tool (TEST) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Toxicity Estimation Software Tool (TEST) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Toxicity Estimation Software Tool (TEST) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Toxicity Estimation Software Tool (TEST) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Toxicity Estimation Software Tool (TEST) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Toxicity Estimation Software Tool (TEST) include Inotiv, Simulations Plus Inc, Schrodinger, Aclaris, Evogene, Deciphex (Patholytix), Exscientia, Instem (Leadscope) and Lhasa Limited, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Toxicity Estimation Software Tool (TEST), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Toxicity Estimation Software Tool (TEST), also provides the revenue of main regions and countries. Of the upcoming market potential for Toxicity Estimation Software Tool (TEST), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Toxicity Estimation Software Tool (TEST) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Toxicity Estimation Software Tool (TEST) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Toxicity Estimation Software Tool (TEST) revenue, projected growth trends, production technology, application and end-user industry.

Toxicity Estimation Software Tool (TEST) Segment by Company

Inotiv

Simulations Plus Inc

Schrodinger

Aclaris

Evogene

Deciphex (Patholytix)

Exscientia

Instem (Leadscope)

Lhasa Limited

MultiCASE

Toxicity Estimation Software Tool (TEST) Segment by Type

On-Premise

Cloud-Based

Toxicity Estimation Software Tool (TEST) Segment by Application

Academia

Enterprise

Toxicity Estimation Software Tool (TEST) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Toxicity Estimation Software Tool (TEST) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Toxicity Estimation Software Tool (TEST) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Toxicity Estimation Software Tool (TEST).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Toxicity Estimation Software Tool (TEST) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Toxicity Estimation Software Tool (TEST) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Toxicity Estimation Software Tool (TEST) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Toxicity Estimation Software Tool (TEST) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. On-Premise Major Player Table 3. Cloud-Based Major Player Table 4. Global Toxicity Estimation Software Tool (TEST) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Academia Major Player Table 6. Enterprise Major Player Table 7. Toxicity Estimation Software Tool (TEST) Industry Trends Table 8. Toxicity Estimation Software Tool (TEST) Industry Drivers Table 9. Toxicity Estimation Software Tool (TEST) Industry Opportunities and Challenges Table 10. Toxicity Estimation Software Tool (TEST) Industry Restraints Table 11. Global Toxicity Estimation Software Tool (TEST) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Toxicity Estimation Software Tool (TEST) Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Toxicity Estimation Software Tool (TEST) Market Share by Region (2021-2026) Table 14. Global Toxicity Estimation Software Tool (TEST) Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Toxicity Estimation Software Tool (TEST) Market Share by Region (2027-2032) Table 16. Global Toxicity Estimation Software Tool (TEST) Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Toxicity Estimation Software Tool (TEST) Revenue Market Share by Players (2021-2026) Table 18. Global Toxicity Estimation Software Tool (TEST) Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Toxicity Estimation Software Tool (TEST) Key Players Headquarters & Area Served Table 20. Global Toxicity Estimation Software Tool (TEST) Players, Product Type & Application Table 21. Global Toxicity Estimation Software Tool (TEST) Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Toxicity Estimation Software Tool (TEST) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Toxicity Estimation Software Tool (TEST) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Toxicity Estimation Software Tool (TEST) Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Toxicity Estimation Software Tool (TEST) Revenue Market Share by Type (2021-2026) Table 28. Global Toxicity Estimation Software Tool (TEST) Revenue Market Share by Type (2027-2032) Table 29. Global Toxicity Estimation Software Tool (TEST) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Toxicity Estimation Software Tool (TEST) Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Toxicity Estimation Software Tool (TEST) Revenue Market Share by Application (2021-2026) Table 33. Global Toxicity Estimation Software Tool (TEST) Revenue Market Share by Application (2027-2032) Table 34. Inotiv Company Information Table 35. Inotiv Business Overview Table 36. Inotiv Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Inotiv Toxicity Estimation Software Tool (TEST) Product Portfolio Table 38. Inotiv Recent Development Table 39. Simulations Plus Inc Company Information Table 40. Simulations Plus Inc Business Overview Table 41. Simulations Plus Inc Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Simulations Plus Inc Toxicity Estimation Software Tool (TEST) Product Portfolio Table 43. Simulations Plus Inc Recent Development Table 44. Schrodinger Company Information Table 45. Schrodinger Business Overview Table 46. Schrodinger Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Schrodinger Toxicity Estimation Software Tool (TEST) Product Portfolio Table 48. Schrodinger Recent Development Table 49. Aclaris Company Information Table 50. Aclaris Business Overview Table 51. Aclaris Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Aclaris Toxicity Estimation Software Tool (TEST) Product Portfolio Table 53. Aclaris Recent Development Table 54. Evogene Company Information Table 55. Evogene Business Overview Table 56. Evogene Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Evogene Toxicity Estimation Software Tool (TEST) Product Portfolio Table 58. Evogene Recent Development Table 59. Deciphex (Patholytix) Company Information Table 60. Deciphex (Patholytix) Business Overview Table 61. Deciphex (Patholytix) Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Deciphex (Patholytix) Toxicity Estimation Software Tool (TEST) Product Portfolio Table 63. Deciphex (Patholytix) Recent Development Table 64. Exscientia Company Information Table 65. Exscientia Business Overview Table 66. Exscientia Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Exscientia Toxicity Estimation Software Tool (TEST) Product Portfolio Table 68. Exscientia Recent Development Table 69. Instem (Leadscope) Company Information Table 70. Instem (Leadscope) Business Overview Table 71. Instem (Leadscope) Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Instem (Leadscope) Toxicity Estimation Software Tool (TEST) Product Portfolio Table 73. Instem (Leadscope) Recent Development Table 74. Lhasa Limited Company Information Table 75. Lhasa Limited Business Overview Table 76. Lhasa Limited Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Lhasa Limited Toxicity Estimation Software Tool (TEST) Product Portfolio Table 78. Lhasa Limited Recent Development Table 79. MultiCASE Company Information Table 80. MultiCASE Business Overview Table 81. MultiCASE Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. MultiCASE Toxicity Estimation Software Tool (TEST) Product Portfolio Table 83. MultiCASE Recent Development Table 84. North America Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2026) & (US$ Million) Table 85. North America Toxicity Estimation Software Tool (TEST) Revenue by Type (2027-2032) & (US$ Million) Table 86. North America Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2026) & (US$ Million) Table 87. North America Toxicity Estimation Software Tool (TEST) Revenue by Application (2027-2032) & (US$ Million) Table 88. North America Toxicity Estimation Software Tool (TEST) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Toxicity Estimation Software Tool (TEST) Revenue by Country (2021-2026) & (US$ Million) Table 90. North America Toxicity Estimation Software Tool (TEST) Revenue by Country (US$ Million) & (2027-2032) Table 91. Europe Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Toxicity Estimation Software Tool (TEST) Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2026) & (US$ Million) Table 94. Europe Toxicity Estimation Software Tool (TEST) Revenue by Application (2027-2032) & (US$ Million) Table 95. Europe Toxicity Estimation Software Tool (TEST) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Toxicity Estimation Software Tool (TEST) Revenue by Country (2021-2026) & (US$ Million) Table 97. Europe Toxicity Estimation Software Tool (TEST) Revenue by Country (US$ Million) & (2027-2032) Table 98. China Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2026) & (US$ Million) Table 99. China Toxicity Estimation Software Tool (TEST) Revenue by Type (2027-2032) & (US$ Million) Table 100. China Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2026) & (US$ Million) Table 101. China Toxicity Estimation Software Tool (TEST) Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2026) & (US$ Million) Table 103. Asia Toxicity Estimation Software Tool (TEST) Revenue by Type (2027-2032) & (US$ Million) Table 104. Asia Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2026) & (US$ Million) Table 105. Asia Toxicity Estimation Software Tool (TEST) Revenue by Application (2027-2032) & (US$ Million) Table 106. Asia Toxicity Estimation Software Tool (TEST) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Asia Toxicity Estimation Software Tool (TEST) Revenue by Region (US$ Million) & (2021-2026) Table 108. Asia Toxicity Estimation Software Tool (TEST) Revenue by Region (US$ Million) & (2027-2032) Table 109. SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2026) & (US$ Million) Table 110. SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Type (2027-2032) & (US$ Million) Table 111. SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2026) & (US$ Million) Table 112. SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Application (2027-2032) & (US$ Million) Table 113. SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Country (2021-2026) & (US$ Million) Table 115. SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Country (US$ Million) & (2027-2032) Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Toxicity Estimation Software Tool (TEST) Image Figure 2. Global Toxicity Estimation Software Tool (TEST) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Toxicity Estimation Software Tool (TEST) Market Size Share 2021 VS 2025 VS 2032 Figure 4. On-Premise Image Figure 5. Cloud-Based Image Figure 6. Global Toxicity Estimation Software Tool (TEST) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Toxicity Estimation Software Tool (TEST) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Academia Image Figure 9. Enterprise Image Figure 10. Global Toxicity Estimation Software Tool (TEST) Market Size (US$ Million) & (2021-2032) Figure 11. Global Toxicity Estimation Software Tool (TEST) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Toxicity Estimation Software Tool (TEST) Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Toxicity Estimation Software Tool (TEST) Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Toxicity Estimation Software Tool (TEST) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Toxicity Estimation Software Tool (TEST) Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Toxicity Estimation Software Tool (TEST) Revenue Market Share by Type (2021-2032) Figure 18. Global Toxicity Estimation Software Tool (TEST) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Toxicity Estimation Software Tool (TEST) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Toxicity Estimation Software Tool (TEST) Revenue Market Share by Application (2021-2032) Figure 21. North America Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Toxicity Estimation Software Tool (TEST) Revenue Share by Type (2021-2032) Figure 23. North America Toxicity Estimation Software Tool (TEST) Revenue Share by Application (2021-2032) Figure 24. North America Toxicity Estimation Software Tool (TEST) Revenue Share by Country (2021-2032) Figure 25. United States Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Toxicity Estimation Software Tool (TEST) Revenue Share by Type (2021-2032) Figure 30. Europe Toxicity Estimation Software Tool (TEST) Revenue Share by Application (2021-2032) Figure 31. Europe Toxicity Estimation Software Tool (TEST) Revenue Share by Country (2021-2032) Figure 32. Germany Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Toxicity Estimation Software Tool (TEST) Revenue Share by Type (2021-2032) Figure 42. China Toxicity Estimation Software Tool (TEST) Revenue Share by Application (2021-2032) Figure 43. Asia Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Toxicity Estimation Software Tool (TEST) Revenue Share by Type (2021-2032) Figure 45. Asia Toxicity Estimation Software Tool (TEST) Revenue Share by Application (2021-2032) Figure 46. Asia Toxicity Estimation Software Tool (TEST) Revenue Share by Region (2021-2032) Figure 47. Japan Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Toxicity Estimation Software Tool (TEST) Revenue Share by Type (2021-2032) Figure 55. SAMEA Toxicity Estimation Software Tool (TEST) Revenue Share by Application (2021-2032) Figure 56. SAMEA Toxicity Estimation Software Tool (TEST) Revenue Share by Country (2021-2032) Figure 57. Brazil Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Toxicity Estimation Software Tool (TEST) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • On-Premise
  • Cloud-Based
Applications
  • Academia
  • Enterprise
Companies covered
  • Inotiv
  • Simulations Plus Inc
  • Schrodinger
  • Aclaris
  • Evogene
  • Deciphex (Patholytix)
  • Exscientia
  • Instem (Leadscope)
  • Lhasa Limited
  • MultiCASE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Toxicity Estimation Software Tool (TEST) Market by Type
  3. 1.2.1 Global Toxicity Estimation Software Tool (TEST) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 On-Premise
  5. 1.2.3 Cloud-Based
  6. 1.3 Toxicity Estimation Software Tool (TEST) Market by Application
  7. 1.3.1 Global Toxicity Estimation Software Tool (TEST) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Academia
  9. 1.3.3 Enterprise
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Toxicity Estimation Software Tool (TEST) Market Dynamics
  1. 2.1 Toxicity Estimation Software Tool (TEST) Industry Trends
  2. 2.2 Toxicity Estimation Software Tool (TEST) Industry Drivers
  3. 2.3 Toxicity Estimation Software Tool (TEST) Industry Opportunities and Challenges
  4. 2.4 Toxicity Estimation Software Tool (TEST) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Toxicity Estimation Software Tool (TEST) Market Perspective (2021-2032)
  2. 3.2 Global Toxicity Estimation Software Tool (TEST) Growth Trends by Region
  3. 3.2.1 Global Toxicity Estimation Software Tool (TEST) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Toxicity Estimation Software Tool (TEST) Market Size by Region (2021-2026)
  5. 3.2.3 Global Toxicity Estimation Software Tool (TEST) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Toxicity Estimation Software Tool (TEST) Revenue by Players
  2. 4.1.1 Global Toxicity Estimation Software Tool (TEST) Revenue by Players (2021-2026)
  3. 4.1.2 Global Toxicity Estimation Software Tool (TEST) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Toxicity Estimation Software Tool (TEST) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Toxicity Estimation Software Tool (TEST) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Toxicity Estimation Software Tool (TEST) Key Players Headquarters & Area Served
  7. 4.4 Global Toxicity Estimation Software Tool (TEST) Players, Product Type & Application
  8. 4.5 Global Toxicity Estimation Software Tool (TEST) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Toxicity Estimation Software Tool (TEST) Market CR5 and HHI
  11. 4.6.3 2025 Toxicity Estimation Software Tool (TEST) Tier 1, Tier 2, and Tier 3
5 Toxicity Estimation Software Tool (TEST) Market Size by Type
  1. 5.1 Global Toxicity Estimation Software Tool (TEST) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2032)
  3. 5.3 Global Toxicity Estimation Software Tool (TEST) Revenue Market Share by Type (2021-2032)
6 Toxicity Estimation Software Tool (TEST) Market Size by Application
  1. 6.1 Global Toxicity Estimation Software Tool (TEST) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2032)
  3. 6.3 Global Toxicity Estimation Software Tool (TEST) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Inotiv
  2. 7.1.1 Inotiv Company Information
  3. 7.1.2 Inotiv Business Overview
  4. 7.1.3 Inotiv Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Inotiv Toxicity Estimation Software Tool (TEST) Product Portfolio
  6. 7.1.5 Inotiv Recent Developments
  7. 7.2 Simulations Plus Inc
  8. 7.2.1 Simulations Plus Inc Company Information
  9. 7.2.2 Simulations Plus Inc Business Overview
  10. 7.2.3 Simulations Plus Inc Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Simulations Plus Inc Toxicity Estimation Software Tool (TEST) Product Portfolio
  12. 7.2.5 Simulations Plus Inc Recent Developments
  13. 7.3 Schrodinger
  14. 7.3.1 Schrodinger Company Information
  15. 7.3.2 Schrodinger Business Overview
  16. 7.3.3 Schrodinger Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Schrodinger Toxicity Estimation Software Tool (TEST) Product Portfolio
  18. 7.3.5 Schrodinger Recent Developments
  19. 7.4 Aclaris
  20. 7.4.1 Aclaris Company Information
  21. 7.4.2 Aclaris Business Overview
  22. 7.4.3 Aclaris Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Aclaris Toxicity Estimation Software Tool (TEST) Product Portfolio
  24. 7.4.5 Aclaris Recent Developments
  25. 7.5 Evogene
  26. 7.5.1 Evogene Company Information
  27. 7.5.2 Evogene Business Overview
  28. 7.5.3 Evogene Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Evogene Toxicity Estimation Software Tool (TEST) Product Portfolio
  30. 7.5.5 Evogene Recent Developments
  31. 7.6 Deciphex (Patholytix)
  32. 7.6.1 Deciphex (Patholytix) Company Information
  33. 7.6.2 Deciphex (Patholytix) Business Overview
  34. 7.6.3 Deciphex (Patholytix) Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Deciphex (Patholytix) Toxicity Estimation Software Tool (TEST) Product Portfolio
  36. 7.6.5 Deciphex (Patholytix) Recent Developments
  37. 7.7 Exscientia
  38. 7.7.1 Exscientia Company Information
  39. 7.7.2 Exscientia Business Overview
  40. 7.7.3 Exscientia Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Exscientia Toxicity Estimation Software Tool (TEST) Product Portfolio
  42. 7.7.5 Exscientia Recent Developments
  43. 7.8 Instem (Leadscope)
  44. 7.8.1 Instem (Leadscope) Company Information
  45. 7.8.2 Instem (Leadscope) Business Overview
  46. 7.8.3 Instem (Leadscope) Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Instem (Leadscope) Toxicity Estimation Software Tool (TEST) Product Portfolio
  48. 7.8.5 Instem (Leadscope) Recent Developments
  49. 7.9 Lhasa Limited
  50. 7.9.1 Lhasa Limited Company Information
  51. 7.9.2 Lhasa Limited Business Overview
  52. 7.9.3 Lhasa Limited Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Lhasa Limited Toxicity Estimation Software Tool (TEST) Product Portfolio
  54. 7.9.5 Lhasa Limited Recent Developments
  55. 7.10 MultiCASE
  56. 7.10.1 MultiCASE Company Information
  57. 7.10.2 MultiCASE Business Overview
  58. 7.10.3 MultiCASE Toxicity Estimation Software Tool (TEST) Revenue and Gross Margin (2021-2026)
  59. 7.10.4 MultiCASE Toxicity Estimation Software Tool (TEST) Product Portfolio
  60. 7.10.5 MultiCASE Recent Developments
8 North America
  1. 8.1 North America Toxicity Estimation Software Tool (TEST) Revenue (2021-2032)
  2. 8.2 North America Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2032)
  3. 8.2.1 North America Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2026)
  4. 8.2.2 North America Toxicity Estimation Software Tool (TEST) Revenue by Type (2027-2032)
  5. 8.3 North America Toxicity Estimation Software Tool (TEST) Revenue Share by Type (2021-2032)
  6. 8.4 North America Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2032)
  7. 8.4.1 North America Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2026)
  8. 8.4.2 North America Toxicity Estimation Software Tool (TEST) Revenue by Application (2027-2032)
  9. 8.5 North America Toxicity Estimation Software Tool (TEST) Revenue Share by Application (2021-2032)
  10. 8.6 North America Toxicity Estimation Software Tool (TEST) Revenue by Country
  11. 8.6.1 North America Toxicity Estimation Software Tool (TEST) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Toxicity Estimation Software Tool (TEST) Revenue by Country (2021-2026)
  13. 8.6.3 North America Toxicity Estimation Software Tool (TEST) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Toxicity Estimation Software Tool (TEST) Revenue (2021-2032)
  2. 9.2 Europe Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Toxicity Estimation Software Tool (TEST) Revenue by Type (2027-2032)
  5. 9.3 Europe Toxicity Estimation Software Tool (TEST) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Toxicity Estimation Software Tool (TEST) Revenue by Application (2027-2032)
  9. 9.5 Europe Toxicity Estimation Software Tool (TEST) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Toxicity Estimation Software Tool (TEST) Revenue by Country
  11. 9.6.1 Europe Toxicity Estimation Software Tool (TEST) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Toxicity Estimation Software Tool (TEST) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Toxicity Estimation Software Tool (TEST) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Toxicity Estimation Software Tool (TEST) Revenue (2021-2032)
  2. 10.2 China Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2032)
  3. 10.2.1 China Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2026)
  4. 10.2.2 China Toxicity Estimation Software Tool (TEST) Revenue by Type (2027-2032)
  5. 10.3 China Toxicity Estimation Software Tool (TEST) Revenue Share by Type (2021-2032)
  6. 10.4 China Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2032)
  7. 10.4.1 China Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2026)
  8. 10.4.2 China Toxicity Estimation Software Tool (TEST) Revenue by Application (2027-2032)
  9. 10.5 China Toxicity Estimation Software Tool (TEST) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Toxicity Estimation Software Tool (TEST) Revenue (2021-2032)
  2. 11.2 Asia Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Toxicity Estimation Software Tool (TEST) Revenue by Type (2027-2032)
  5. 11.3 Asia Toxicity Estimation Software Tool (TEST) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Toxicity Estimation Software Tool (TEST) Revenue by Application (2027-2032)
  9. 11.5 Asia Toxicity Estimation Software Tool (TEST) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Toxicity Estimation Software Tool (TEST) Revenue by Country
  11. 11.6.1 Asia Toxicity Estimation Software Tool (TEST) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Toxicity Estimation Software Tool (TEST) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Toxicity Estimation Software Tool (TEST) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Toxicity Estimation Software Tool (TEST) Revenue (2021-2032)
  2. 12.2 SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Toxicity Estimation Software Tool (TEST) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Toxicity Estimation Software Tool (TEST) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Country
  11. 12.6.1 SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Toxicity Estimation Software Tool (TEST) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst